STJ  St. Jude Medical Inc.




Health Care


Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.


Vuru Grade


Current Price

-1.22 (-1.81%)

Growth Price

Overvalued by 40.48%

Stability Price

Overvalued by 69.18%

Company Metrics

  • 22.26 P/E
  • 3.44 P/S
  • 4.70 P/B
  • 3.027 EPS
  • 13.07% Cash ROIC
  • 0.99 Cash Ratio
  • 1.08 / 1.60 % Dividend
  • 1.97M Avg. Vol.
  • 18.919B Market Cap.

Company Description

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab...

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


St. Jude Medical earnings meet expectations
Minneapolis Star Tribune - Jan 28, 2015
St. Jude Medical Inc. is giving upbeat sales predictions for 2015, but the heart-device maker will have to battle against a strong dollar to meet its targets.
St. Jude Medical gives downbeat profit outlook - MarketWatch
Can St. Jude Medical (STJ) Keep Earnings Streak Alive? - Jan 27, 2015
Last quarter, the company reported earnings of 97 cents per share, which beat the Zacks Consensus Estimate by a penny. In fact, in all the past four quarters, St. Jude Medical's earnings have outpaced the Zacks Consensus Estimate with an average beat ...
St. Jude Medical Q4 Earnings and Revenues In Line - Jan 28, 2015
St. Jude Medical, Inc. (STJ) is one of the leading worldwide manufacturers of innovative cardiovascular and implantable neuro-stimulation medical devices.
St. Jude Medical Q4 Results Meet Estimates, But Issues Weak Outlook
Nasdaq - Jan 28, 2015
( - Cardiovascular medical devices maker St. Jude Medical, Inc. ( STJ ) reported Wednesday a profit for the fourth quarter that doubled from last year, reflecting lower charges and sales growth.
St. Jude Medical Announces FDA Approval of FlexAbility Ablation Catheter
Business Wire (press release) - Jan 27, 2015
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced U.S.
Company Update: St. Jude Medical Inc (NYSE:STJ) - St. Jude Medical ... - Jutia Group
St. Jude Medical Q4 Adj. Profit Tops View - Quick Facts
Nasdaq - Jan 28, 2015
Looking ahead to the first quarter, St. Jude Medical expects consolidated adjusted net earnings to be in the range of $0.90 to $0.92 per share and revenue to grow in the range of 2 percent to 4 percent on a constant currency basis with currency ...
St. Jude Medical Reports Fourth Quarter and Full-Year 2014 Results
MarketWatch - Jan 28, 2015
Commenting on the company's financial results, St. Jude Medical Chairman, President and Chief Executive Officer Daniel J. Starks said, “We're delivering on our commitment to improving patient outcomes and reducing the economic burden of conditions ...
St. Jude Medical, Inc. (STJ) Releases FY15 Earnings Guidance
WKRB News - 5 hours ago
St. Jude Medical logo St. Jude Medical, Inc. (NYSE:STJ) updated its FY15 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $3.95-4.00 for the period, compared to the Thomson Reuters consensus estimate of ...
St. Jude Medical (STJ) Earnings Report: Q4 2014 Conference Call Transcript - Jan 28, 2015
... provide information pertinent to ongoing business performance. Tables reconciling these measures to most comparable GAAP measures are available on the Company's press release issued earlier this morning, or on the St. Jude Medical Web site at www.
Can St. Jude Medical (STJ) Keep Earnings Streak Alive? - Analyst Blog
Nasdaq - Jan 28, 2015
Global medical devices company, St. Jude Medical, Inc. ( STJ ), is scheduled to report fourth-quarter and full-year 2014 financial numbers on Jan 28, before the opening bell.